Femasys Inc. Financing Cash Flow
Femasys Inc. (FEMY) reported Financing Cash Flow of $357.66 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- Femasys Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $15.33K, a 99.60% decline year-over-year.
- Femasys Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $342.33K, a 93.45% decline year-over-year.
- Femasys Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $9.08M, a 785.15% increase year-over-year.
- Femasys Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $6.98M.
- Femasys Inc. net cash provided by (used in) financing activities for fiscal 2025 was $25.14M, a 1139.74% increase from fiscal 2024.
- Femasys Inc. net cash provided by (used in) financing activities for fiscal 2024 was $2.03M, a 89.95% decline from fiscal 2023.
- Femasys Inc. net cash provided by (used in) financing activities for fiscal 2023 was $20.18M.
- Femasys Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$681.64K, a 102.30% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $357.66K 10-Q · filed 2026-08-14 | $9.44M derived: sum of 3 quarters · filed 2026-08-14 | $16.42M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $342.33K 10-Q · filed 2026-05-08 | $9.42M derived: sum of 2 quarters · filed 2026-05-08 | $16.40M derived: sum of 3 quarters · filed 2026-05-08 | $20.25M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $9.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $16.06M derived: sum of 2 quarters · filed 2026-03-31 | $19.90M derived: sum of 3 quarters · filed 2026-08-14 | $25.14M 10-K · filed 2026-03-31 |
| 2025-09-30 | $6.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $10.83M derived: sum of 2 quarters · filed 2026-08-14 | $16.06M 10-Q · filed 2025-11-14 | $17.08M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $9.08M 10-Q · filed 2026-08-14 | $10.10M derived: sum of 3 quarters · filed 2026-08-14 | $10.10M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $5.23M 10-Q · filed 2026-05-08 | $6.26M derived: sum of 2 quarters · filed 2026-05-08 | $6.26M derived: sum of 3 quarters · filed 2026-05-08 | $6.48M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.03M derived: sum of 2 quarters · filed 2026-03-31 | $1.25M derived: sum of 3 quarters · filed 2026-03-31 | $2.03M 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $223.55K derived: sum of 2 quarters · filed 2025-11-14 | $1.00M 10-Q · filed 2025-11-14 | $17.11M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $223.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.00M 10-Q · filed 2025-08-08 | $17.11M derived: sum of 3 quarters · filed 2025-08-08 | $17.98M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $778.17K 10-Q · filed 2025-05-08 | $16.88M derived: sum of 2 quarters · filed 2025-05-08 | $17.75M derived: sum of 3 quarters · filed 2025-05-08 | $21.10M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $16.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $16.97M derived: sum of 2 quarters · filed 2025-03-27 | $20.32M derived: sum of 3 quarters · filed 2025-03-27 | $20.18M 10-K · filed 2025-03-27 |
| 2023-09-30 | $870.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.22M derived: sum of 2 quarters · filed 2024-11-12 | $4.07M 10-Q · filed 2024-11-12 | $3.99M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.20M 10-Q · filed 2024-08-08 | $3.12M derived: sum of 3 quarters · filed 2024-08-08 | $2.76M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$144.06K 10-Q · filed 2024-05-09 | -$226.01K derived: sum of 2 quarters · filed 2024-05-09 | -$588.05K derived: sum of 3 quarters · filed 2024-05-09 | -$684.70K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$81.95K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$443.99K derived: sum of 2 quarters · filed 2024-03-28 | -$540.64K derived: sum of 3 quarters · filed 2024-03-28 | -$681.64K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$362.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$458.69K derived: sum of 2 quarters · filed 2023-11-14 | -$599.70K 10-Q · filed 2023-11-14 | -$730.45K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$96.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$237.66K 10-Q · filed 2023-08-10 | -$368.41K derived: sum of 3 quarters · filed 2023-08-10 | -$969.74K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$141.01K 10-Q · filed 2023-05-11 | -$271.76K derived: sum of 2 quarters · filed 2023-07-24 | -$873.09K derived: sum of 3 quarters · filed 2023-07-24 | $29.70M derived: sum of 4 quarters · filed 2023-07-24 |
| 2021-12-31 | -$130.75K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | -$732.08K derived: sum of 2 quarters · filed 2023-07-24 | $29.84M derived: sum of 3 quarters · filed 2023-07-24 | $29.70M 10-K/A · filed 2023-07-24 |
| 2021-09-30 | -$601.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $29.97M derived: sum of 2 quarters · filed 2022-11-10 | $29.83M 10-Q · filed 2022-11-10 | $29.84M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $30.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $30.43M 10-Q · filed 2022-08-10 | $30.44M derived: sum of 3 quarters · filed 2022-08-10 | $30.44M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$144.99K 10-Q · filed 2022-05-11 | -$137.42K derived: sum of 2 quarters · filed 2022-05-11 | -$139.44K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $7.58K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $5.55K derived: sum of 2 quarters · filed 2022-03-24 | $871.65K 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$2.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $864.07K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $866.10K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |